Clinical trial
Phase I/II Study of Total Body Irradiation, Cyclophosphamide, and Fludarabine…
NCT00005898 · University of Minnesota, Other · Completed
Key facts
| NCT number | NCT00005898 |
|---|---|
| Title | Phase I/II Study of Total Body Irradiation, Cyclophosphamide, and Fludarabine Followed by Alternate Donor Hematopoietic Cell Transplantation in Patients With Fanconi's Anemia |
| Lead sponsor | University of Minnesota, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Fanconi's Anemia |
| Intervention type | Drug |
| Interventions | anti-thymocyte globulin, cyclophosphamide, cyclosporine, filgrastim, fludarabine, methylprednisolone |
| Enrollment | 30 |
| Start date | Feb 1, 2000 |
| First posted | Jun 5, 2000 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: